HUMAN GRANULOCYTE ISOLATION BY CONTINUOUS-FLOW CENTRIFUGATION LEUKAPHERESIS AND COUNTERFLOW CENTRIFUGATION ELUTRIATION (CFCL-CCE)

Human granulocytes (PMNL) isolated by continuous flow centriftagatlon leukapheresis (CFCL) were further purified by counterflow centrifugation elutriation (CCE). Studies were conducted to determine the maximal granulocyte capacity of the 4.5‐ml elutriation chamber and to determine the efficiency of granulocyte recovery from CFCL concentrates. The maximal capacity of the elutriation chamber was determined to be 1.30 times 109 granulocytes with a 98.8 per cent granulocyte purity and a 51:1 PMNL/RBC ratio. The efficiency of recovery was 82.2 per cent with a 95.1 per cent granulocyte purity and a 68:1 PMNL/RBC ratio. The CCE flow system was designed to allow continuous elutriation runs without need of breakdown time between runs. In four to five hours, approximately 4 to 5 times 109 granulocytes can be isolated with purity in excess of 95 per cent. In vitro analysis of the viability and function of CFCL/CCE‐isolated granulocytes indicates that the morphologic integrity and physiologic function were not comprised as a result of the combined isolation procedure relative to granulocytes isolated by CCE from whole blood samples. Granulocytes were held at 4 to 6 C for 16 to 24 hours in granulocyte storage medium (GSM) plus 20 per cent autologous plasma at concentrations of about 6 times 106 PMNL/ml prior to in vitro analysis. 1979 AABB